| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $3.01M | $0.00 | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | $588.93K | $0.00 | – | – | – |
| Operating Expenses | $761.03K | $1.58M | $1.48M | $1.52M | – |
| R&D | – | – | – | – | – |
| SG&A | $71.69K | $116.27K | $138.05K | $170.16K | $193.13K |
| Operating Income | -$172.10K | -$1.58M | -$1.48M | -$1.52M | -$1.98M |
| Interest Expense | $2.87M | $2.50M | $2.19M | $1.82M | $1.75M |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$69.30M | -$1.19M | -$9.15M | -$6.91M | -$2.67M |
| EPS (basic) | – | – | – | -0.0400 | -0.0200 |
| EPS (diluted) | 0.3400 | -0.0100 | -0.0500 | – | – |
| Shares (diluted) | $202.00M | $188.72M | $184.37M | – | – |